Stay updated on PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.

Latest updates to the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 was removed, indicating a minor administrative update to the study record rather than a change to trial information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing v3.6.2, indicating a small system update rather than a change to study content.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page now shows a newer revision: v3.6.2, updating the displayed version of the ClinicalTrials.gov record. This indicates a minor update to the study details or related content on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and recruitment status (No longer looking for participants); updated the revision to v3.6.0 and removed the old 'Intervention / Treatment' label along with the prior v3.5.5 reference.SummaryDifference0.4%

- Check56 days agoChange DetectedThe page shows a new revision label, v3.5.5, replacing the previous v3.5.4 in the site’s revision metadata. This indicates a minor metadata update rather than a change to the study content.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor documentation/version update. It does not introduce new content or alter the page's visible data.SummaryDifference0.0%

Stay in the know with updates to PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.